Angiogenic therapy of the human heart.
- 24 February 1998
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (7), 628-629
- https://doi.org/10.1161/01.cir.97.7.628
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Fighting Cancer by Attacking its Blood SupplyScientific American, 1996
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Heparin Binds Endothelial Cell Growth Factor, the Principal Endothelial Cell Mitogen in Bovine BrainScience, 1984
- Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth FactorScience, 1984
- Protamine is an inhibitor of angiogenesisNature, 1982
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971